# Morphochem

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/morphochem

- Industry: Biotechnology
- Headquarters: Munich, Germany
- Total disclosed funding: $53M
- Latest round: Series D (Jul 19, 2001)
- Investors on record: 11

## About

Morphochem is a biotechnology firm engages in the discovers and development of drugs.

## Funding rounds

- Series D, Jul 19, 2001, $15M — Alta Berkeley, Alta Partners, Meriten Investment Management, TVM Capital Life Science, Excalibur Fund Managers, EQT Life Sciences, Nomura Asset Management
- Series C, Aug 2, 2000, $38M — 3i, Alta Berkeley, Alta Partners, Domain Associates, Meriten Investment Management, TVM Capital Life Science, Excalibur Fund Managers, IKB Invest, Nomura Asset Management, Julius Baer Pension Fund

## Investors

- 3i (https://capitalatlas.ai/funds/3i) — Series C
- Alta Berkeley (https://capitalatlas.ai/funds/alta-berkeley) — Series C, Series D
- Alta Partners (https://capitalatlas.ai/funds/alta-partners) — Series C, Series D
- Domain Associates (https://capitalatlas.ai/funds/domain-associates) — Series C
- Meriten Investment Management (https://capitalatlas.ai/funds/meriten-investment-management) — Series C, Series D
- TVM Capital Life Science (https://capitalatlas.ai/funds/tvm-capital-life-science) — Series C, Series D
- Excalibur Fund Managers (https://capitalatlas.ai/funds/excalibur-fund-managers) — Series C, Series D
- IKB Invest (https://capitalatlas.ai/funds/ikb-invest) — Series C
- Nomura Asset Management (https://capitalatlas.ai/funds/nomura-asset-management) — Series C, Series D
- Julius Baer Pension Fund — Series C
- EQT Life Sciences (https://capitalatlas.ai/funds/eqt-life-sciences) — Series D